Form 4: ProAssurance Corp Merger Completes, Executive Ownership Changes
Statement of Changes in Beneficial Ownership
ProAssurance Corporation's merger with The Doctors Company subsidiary has been finalized, resulting in executive stock unit conversions and cash payouts.
Summary
- The filing details the completion of the merger between ProAssurance Corporation and The Doctors Company, effective June 26, 2026.
- As a result of the merger, ProAssurance Corporation is now a wholly owned subsidiary of The Doctors Company.
- Jeffrey Lisenby, Executive Vice-President and Secretary & General Counsel, had his restricted stock units (RSUs) converted into cash.
- The merger consideration for each share of ProAssurance common stock was $25.00 in cash.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it reports on a completed merger and executive ownership changes rather than new financial performance or strategic initiatives.
Positives
- The merger has been successfully completed, indicating a significant strategic event for ProAssurance Corporation.
- Executives like Jeffrey Lisenby received a cash payout for their restricted stock units, providing immediate value.
- The transaction was executed on the planned date of June 26, 2026.
Negatives
- The filing indicates the cancellation of common stock and RSUs in exchange for cash, meaning existing shareholders and RSU holders no longer hold equity in ProAssurance Corporation directly.
- The specific details of the 'excluded shares' and 'excluded RSUs' that were forfeited are not elaborated upon, which could represent a loss for certain holders.
Risks
- The filing does not explicitly mention any ongoing risks or future challenges related to the merger's integration or operational impact.
- Potential risks associated with the forfeiture of certain RSUs are not detailed.
Future Outlook
The filing primarily reports on a completed transaction and does not contain forward-looking statements or guidance regarding future performance of the combined entity.
Management Comments
- The filing is a Form 4, which reports changes in beneficial ownership and does not typically include direct management commentary on strategy or performance.
- The Power of Attorney document indicates that Jeffrey P. Lisenby has appointed attorneys-in-fact to prepare and execute SEC filings on his behalf.
Industry Context
StockSavvy.ai notes that this Form 4 filing signifies the completion of a significant M&A event in the insurance sector, specifically within the medical professional liability space, following the merger of ProAssurance Corporation with The Doctors Company.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Vice-President, Secretary & General Counsel | Jeffrey Patton Lisenby | 06/26/2026 | Merger completion, resulting in conversion of equity interests to cash. |
Stakeholder Impact
- Shareholders: Former ProAssurance Corporation shareholders received $25.00 per share in cash, concluding their equity interest in the company.
- Employees: The filing does not detail the impact on employees, but as ProAssurance is now a subsidiary, there may be integration-related changes.
- Management: Executives holding RSUs received cash payouts, as detailed for Jeffrey Lisenby.
Next Steps
- ProAssurance Corporation will operate as a wholly owned subsidiary of The Doctors Company.
- Further filings may be required to reflect ongoing changes in beneficial ownership or corporate structure.
Key Dates
| Date | Description |
|---|---|
| 05/22/2019 | Date of execution of the Power of Attorney by Jeffrey P. Lisenby. |
| 03/19/2025 | Date of the Agreement and Plan of Merger. |
| 06/26/2026 | Effective date of the Merger and the earliest transaction date reported in the filing. |
Keywords
ProAssurance Corporation, Merger, The Doctors Company, Form 4, SEC Filing, Executive Compensation, Restricted Stock Units, Beneficial Ownership, Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.